Roszet
Developed for hypercholesterolaemia, intended to target cholesterol synthesis and absorption to alleviate lipid levels and support cardiovascular health.
Strengths: 10/10mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
HMG-CoA Reductase Inhibitor; Cholesterol Absorption Inhibitor
- Pharmacological class
Statin; Azetidinone
- Contraindications
active liver disease; pregnancy; breastfeeding
- Minor side effects
headache; constipation
- Moderate side effects
myalgia; increased liver enzymes; asthenia
- Serious side effects
rhabdomyolysis — requires immediate medical attention
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
AstraZeneca
- Onset Time
1–2 weeks
- Duration
24 hours
- Storage instructions
Store at room temperature.
- Drug interactions
ciclosporin; warfarin
- Age restrictions
Not recommended in children.
- Pregnancy and breastfeeding
Pregnancy: Contraindicated. Breastfeeding: Contraindicated.
Precautions and warnings
monitor liver enzymes; watch for unexplained muscle pain; risk of diabetes mellitus
Patient summary
Developed for hypercholesterolaemia, intended to target cholesterol synthesis and absorption to alleviate lipid levels and support cardiovascular health.
Mechanism of action
This combination contains a statin and ezetimibe. It reduces cholesterol by inhibiting its production in the liver and decreasing its absorption from the intestine, which effectively lowers overall LDL cholesterol levels.
Roszet
Developed for hypercholesterolaemia, intended to target cholesterol synthesis and absorption to alleviate lipid levels and support cardiovascular health.
Editorial Notes
- Active ingredient(s): Rosuvastatin, Ezetimibe
- Listed indication(s): Hypercholesterolaemia
Available option
- 90 tablets - 10/10 mg1537-10-10-mg-17971